마이크로니들 인플루엔자 백신 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품 유형별, 백신 유형별, 지역별, 경쟁별(2020-2030년)

The Global Microneedle Flu Vaccine Market, valued at USD 1.18 Billion in 2024, is projected to experience a CAGR of 5.96% to reach USD 1.67 Billion by 2030. The global microneedle flu vaccine is an innovative delivery system utilizing microscopic needles, typically integrated into a patch, to administer the influenza vaccine into the superficial layers of the skin, offering a less invasive alternative to traditional intramuscular injections. This market's growth is primarily driven by the increasing demand for painless and self-administered vaccination methods, aiming to reduce needle phobia and enhance patient compliance globally.

Key Market Drivers

The global microneedle flu vaccine market is primarily influenced by the rising demand for painless and self-administered vaccination methods and continuous advancements in microneedle technology. The desire for less invasive vaccine delivery is a significant driver, addressing widespread needle phobia and improving patient compliance, which traditionally pose barriers to vaccination uptake. For instance, according to a study published in the *Journal of Multidisciplinary Healthcare*, in May 2024, "Prevalence, factors associated and management of needle phobia among the general population in Saudi Arabia and Egypt", approximately 36.5% of adult participants reported experiencing needle phobia, highlighting a substantial population that could benefit from alternative administration routes.

Key Market Challenges

The complex and stringent regulatory approval process for novel drug delivery systems presents a significant obstacle to the expansion of the global microneedle flu vaccine market. As products combining both a medical device and a biologic, microneedle vaccines are subject to extensive and rigorous requirements for clinical trials. These trials must rigorously demonstrate the safety, efficacy, and consistent manufacturing scalability of the integrated system.

Key Market Trends

The shift towards dissolvable microneedle technologies marks a notable advancement in vaccine delivery, offering enhanced patient comfort and safety by eliminating sharp biohazardous waste. These biodegradable polymer-based patches dissolve within the skin, facilitating precise and sustained antigen release, which can improve vaccine efficacy and potentially allow for reduced dosage requirements. This trend underscores the industry's commitment to innovation in materials science for medical applications.

Key Market Players

• Debiotech S.A.
• NanoPass Technologies Limited
• Becton, Dickinson and Company
• FluGen, Inc.
• CosMED Pharmaceuticals Co., Ltd.
• Microdermics Inc.
• TSRL Inc.
• Vaxess Technologies Inc.
• Pfizer, Inc.
• Merck & Co., Inc.

Report Scope:

In this report, the Global Microneedle Flu Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microneedle Flu Vaccine Market, By Product Type:

• Solid Microneedle
• Hollow Microneedle

Microneedle Flu Vaccine Market, By Vaccine Type:

• Trivalent Flu Vaccine
• Quadrivalent Flu Vaccine

Microneedle Flu Vaccine Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Microneedle Flu Vaccine Market.

Available Customizations:

Global Microneedle Flu Vaccine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microneedle Flu Vaccine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Solid Microneedle, Hollow Microneedle)
  • 5.2.2. By Vaccine Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Microneedle Flu Vaccine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Vaccine Type
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Microneedle Flu Vaccine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Vaccine Type
  • 6.3.2. Canada Microneedle Flu Vaccine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Vaccine Type
  • 6.3.3. Mexico Microneedle Flu Vaccine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Vaccine Type

7. Europe Microneedle Flu Vaccine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Vaccine Type
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Microneedle Flu Vaccine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Vaccine Type
  • 7.3.2. France Microneedle Flu Vaccine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Vaccine Type
  • 7.3.3. United Kingdom Microneedle Flu Vaccine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Vaccine Type
  • 7.3.4. Italy Microneedle Flu Vaccine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Vaccine Type
  • 7.3.5. Spain Microneedle Flu Vaccine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Vaccine Type

8. Asia Pacific Microneedle Flu Vaccine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Vaccine Type
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Microneedle Flu Vaccine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Vaccine Type
  • 8.3.2. India Microneedle Flu Vaccine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Vaccine Type
  • 8.3.3. Japan Microneedle Flu Vaccine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Vaccine Type
  • 8.3.4. South Korea Microneedle Flu Vaccine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Vaccine Type
  • 8.3.5. Australia Microneedle Flu Vaccine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Vaccine Type

9. Middle East & Africa Microneedle Flu Vaccine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Vaccine Type
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Microneedle Flu Vaccine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Vaccine Type
  • 9.3.2. UAE Microneedle Flu Vaccine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Vaccine Type
  • 9.3.3. South Africa Microneedle Flu Vaccine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Vaccine Type

10. South America Microneedle Flu Vaccine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Vaccine Type
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Microneedle Flu Vaccine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Vaccine Type
  • 10.3.2. Colombia Microneedle Flu Vaccine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Vaccine Type
  • 10.3.3. Argentina Microneedle Flu Vaccine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Vaccine Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Microneedle Flu Vaccine Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Debiotech S.A.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. NanoPass Technologies Limited
• 15.3. Becton, Dickinson and Company
• 15.4. FluGen, Inc.
• 15.5. CosMED Pharmaceuticals Co., Ltd.
• 15.6. Microdermics Inc.
• 15.7. TSRL Inc.
• 15.8. Vaxess Technologies Inc.
• 15.9. Pfizer, Inc.
• 15.10. Merck & Co., Inc.

16. Strategic Recommendations

17. About Us & Disclaimer